TMCnet News

Research and Markets: Tinnitus Global Clinical Trials Review, H1, 2012
[March 01, 2012]

Research and Markets: Tinnitus Global Clinical Trials Review, H1, 2012


DUBLIN --(Business Wire)--

Research and Markets(http://www.researchandmarkets.com/research/7966a6/tinnitus_global_cl) has announced the addition of GlobalData's new report "Tinnitus Global Clinical Trials Review, H1, 2012" to their offering.

GlobalData's clinical trial report, Tinnitus Global Clinical Trials Review, H1, 2012" provides data on the Tinnitus clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Tinnitus. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Tinnitus. This repot is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Key Topics Covered:

  • Introduction
  • Tinnitus
  • Report Guidance
  • Clinical Trials by Region
  • Clinical Trials by Country
  • Top Countries Contributing to Clinical Trials in Asia-Pacific
  • Top Five Countries Contributing to Clinical Trials in Europe
  • Top Countries Contributing to Clinical Trials in North America
  • Top Countries Contributing to Clinical Trials in Middle East and Africa
  • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by BRIC Nations
  • Clinical Trials by G7 Nations
  • Clinical Trials in G7 Nations by Trial Status
  • Clinical Trials by E7 Nations
  • Clinical Trials in E7 Nations by Trial Status
  • Clinical Trials by Phase
  • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Unaccomplished Trials of Tinnitus
  • Subjects Recruited Over a Period of Time
  • Prominent Sponsors
  • Top Companies Participating in Tinnitus Therapeutics Clinical Trials
  • Prominent Drug Comparison
  • Clinical Trial Profiles
  • Clinical Trial Overview of Top Companies
  • Five Key Clinical Profiles
  • Appendix
  • Abbreviations
  • Definitions
  • Research Methodology
  • Secondary Research

Companies Mentioned:


  • Merz GmbH & Co. KGaA
  • Auris Medical AG
  • Merz Pharmaceuticals, LLC
  • NeuroSystec Corporation
  • Sound Pharmaceuticals, Inc.
  • Phafag AG
  • Orasi Medical, Inc.
  • Bayer AG
  • Novartis AG
  • GlaxoSmithKline plc
  • Washington University School of Medicine
  • Faculdade de Medicina de Valenca
  • The University of Iowa
  • U.S. Department of Veterans Affairs
  • University Hospital Tubingen
  • University Hospital Antwerp
  • Johannes Gutenberg University Mainz
  • Islamic Azad University of Mashhad
  • University Medical Center Groningen
  • Tinnitus Research Consortium
  • Guilan University of Medical Sciences
  • Mayo Clinic
  • Nagasaki University
  • University of Heidelberg
  • London School of Hygiene & Tropical Medicine
  • Asan Medical Center
  • German Research Foundation
  • University of Regensburg
  • Ziv Medical Center
  • University Hospital, Bordeaux

For more information visit http://www.researchandmarkets.com/research/7966a6/tinnitus_global_cl


[ Back To TMCnet.com's Homepage ]